Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial
Open accessPublished version of a preprint
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background: As the increasing prevalence of type 2 diabetes mellitus has put pressure on health systems to appropriately manage these patients, there have been a growing number of mobile apps designed to improve the self-management of diabetes. One such app, BlueStar, has been shown to significantly reduce hemoglobin A1c (HbA1c) levels in small studies and is the first app in the United States to receive Food and Drug Administration approval as a mobile prescription therapy. However, the impact of the app across real-world population among different clinical sites and health systems remains unclear. Objective: The primary objective of this study was to conduct a pragmatic randomized controlled trial of the BlueStar mobile app to determine if app usage leads to improved HbA1c levels among diverse participants in real-life clinical contexts. We hypothesized that this mobile app would improve self-management and HbA1c levels compared with controls. Methods: The study consisted of a multicenter pragmatic randomized controlled trial. Overall, 110 participants randomized to the immediate treatment group (ITG) received the intervention for 6 months, and 113 participants randomized to the wait-list control (WLC) group received usual care for the first 3 months and then received the intervention for 3 months. The primary outcome was glucose control measured by HbA1c levels at 3 months. Secondary outcomes assessed intervention impact on patient self-management, experience of care, and self-reported health utilization using validated scales, including the Problem Areas in Diabetes, the Summary of Diabetes Self-Care Activities, and the EuroQol-5D. Intervention usage data were collected directly from the app. Results: The results of an analysis of covariance controlling for baseline HbA1c levels did not show evidence of intervention impact on HbA1c levels at 3 months (mean difference [ITG−WLC] −0.42, 95% CI −1.05 to 0.21; P=.19). Similarly, there was no intervention effect on secondary outcomes measuring diabetes self-efficacy, quality of life, and health care utilization behaviors. An exploratory analysis of 57 ITG participants investigating the impact of app usage on HbA1c levels showed that each additional day of app use corresponded with a 0.016-point decrease in participants’ 3-month HbA1c levels (95% CI −0.03 to −0.003). App usage varied significantly by site, as participants from 1 site logged in to the app a median of 36 days over 14 weeks (interquartile range [IQR] 10.5-124); those at another site used the app significantly less (median 9; IQR 6-51). Conclusions: The results showed no difference between intervention and control arms for the primary clinical outcome of glycemic control measured by HbA1c levels. Although there was low usage of the app among participants, results indicate contextual factors, particularly site, had a significant impact on overall usage. Future research into the patient and site-specific factors that increase app utilization are needed. Trial Registration: Clinicaltrials.gov NCT02813343; https://clinicaltrials.gov/ct2/show/NCT02813343 (Archived by WebCite at https://clinicaltrials.gov/ct2/show/NCT02813343)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With respect to glycemic control, telehealth appears noninferior (as good or superior) to traditional health care delivery for persons with T1D or T2D, particularly in those who require more interactions, are newly diagnosed, have higher A1C levels, are diagnosed with GDM, or have other comorbid conditions.1673–1681”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1676]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 2×
“Data were collected centrally by research assistants and inputted into the REDCap database.”
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 2×
“Overall, there was no difference in patient-reported diabetes self-care behaviors (measured by PAID and Summary of Diabetes Self-Care Activities-6) or general health status (measured by EQ-5D) at 3 months between intervention arms in both the unadjusted and adjusted models (Multimedia Appendix 5).”
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · cited 1×
“The worldwide burden of type 2 diabetes mellitus (T2DM) continues to increase, with almost 9% of the global population expected to have T2DM by 2035 [1].”
Self-citationEffect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.943 · Cited by 2,561 · cited 2×
“Overall, there was no difference in patient-reported diabetes self-care behaviors (measured by PAID and Summary of Diabetes Self-Care Activities-6) or general health status (measured by EQ-5D) at 3 months between intervention arms in both the unadjusted and adjusted models (Multimedia Appendix 5).”
Eysenbach, G. (2005) · Journal of Medical Internet Research · doi:10.2196/jmir.7.1.e11 · Cited by 2,524 · cited 1×
“5% (77/223), while in line with prior electronic health (eHealth) studies, may have led to an underestimation of the clinical impact among participants [36,37].”
Self-Management Education for Adults With Type 2 Diabetes
Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1159 · Cited by 1,750 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., Tunis, S., Bergel, E., Harvey, I., Magid, D. J., et al. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.12.011 · Cited by 1,389
A Systematic Review of the Impact of Adherence on the Effectiveness of e-Therapies
Donkin, L., Christensen, H., Naismith, S. L., Neal, B., Hickie, I. B., & Glozier, N. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1772 · Cited by 876 · cited 1×
“5% (77/223), while in line with prior electronic health (eHealth) studies, may have led to an underestimation of the clinical impact among participants [36,37].”
Whitehead, L., & Seaton, P. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4883 · Cited by 743 · cited 1×
“There are a growing number of mobile apps designed to improve the self-management of T2DM patients [10-12], although few have been rigorously evaluated.”
The problem areas in diabetes scale: an evaluation of its clinical utility
Welch, G. W., Jacobson, A. M., & Polonsky, W. H. (1997) · Diabetes Care · doi:10.2337/diacare.20.5.760 · Cited by 664 · cited 4×
“Overall, there was no difference in patient-reported diabetes self-care behaviors (measured by PAID and Summary of Diabetes Self-Care Activities-6) or general health status (measured by EQ-5D) at 3 months between intervention arms in both the unadjusted and adjusted models (Multimedia Appendix 5).”
InfluentialO’Connor, S., Hanlon, P., O’Donnell, C. A., Garcia, S., Glanville, J., & Mair, F. S. (2016) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-016-0359-3 · Cited by 636
Powers, M. A., Bardsley, J., Cypress, M., Duker, P., Funnell, M. M., Hess Fischl, A., Maryniuk, M. D., Siminerio, L., & Vivian, E. (2015) · Diabetes Care · doi:10.2337/dc15-0730 · Cited by 492 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
Chomutare, T., Fernandez-Luque, L., Årsand, E., & Hartvigsen, G. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1874 · Cited by 451 · cited 1×
“Given previous evidence on the benefits of strong primary care participation in diabetes self-management apps, the use of DEPs as the primary site of recruitment likely had a negative impact on enrollment, usage, and clinical impact [38,39].”
Hou, C., Carter, B., Hewitt, J., Francisa, T., & Mayor, S. (2016) · Diabetes Care · doi:10.2337/dc16-0346 · Cited by 411 · cited 3×
“However, these tended to have small study populations, and 8 of the 10 studies included additional ongoing feedback from the PCP as part of the intervention [8].”
Quinn, C. C., Clough, S. S., Minor, J. M., Lender, D., Okafor, M. C., & Gruber-Baldini, A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0283 · Cited by 406 · cited 3×
“Moreover, in that study, the intervention arm received the mobile app plus multiple follow-up interactions from the research team to the physician and patient [13].”
InfluentialComputer-based diabetes self-management interventions for adults with type 2 diabetes mellitus
Pal, K., Eastwood, S. V., Michie, S., Farmer, A. J., Barnard, M. L., Peacock, R., Wood, B., Inniss, J. D., & Murray, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008776.pub2 · Cited by 344 · cited 1×
“Although self-management is traditionally offered through in-person educational programs, this is resource intensive, and advances in mobile technology provide the opportunity to deliver effective self-management support to patients that is convenient and potentially cost-effective [6-9].”
Diabetes Management via Mobile Phones: A Systematic Review
Holtz, B., & Lauckner, C. (2012) · Telemedicine and e-Health · doi:10.1089/tmj.2011.0119 · Cited by 318
Powers, M. A., Bardsley, J., Cypress, M., Duker, P., Funnell, M. M., Fischl, A. H., Maryniuk, M. D., Siminerio, L., & Vivian, E. (2016) · Clinical Diabetes · doi:10.2337/diaclin.34.2.70 · Cited by 285
T2DM Self-Management via Smartphone Applications: A Systematic Review and Meta-Analysis
Cui, M., Wu, X., Mao, J., Wang, X., & Nie, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166718 · Cited by 269 · cited 1×
“Several recent studies of apps for T2DM have emphasized the importance of an implementation that includes a strong clinical endorsement and ongoing clinical support to increase overall usage [33,34].”
BackgroundMobile health applications to assist patients with diabetes: lessons learned and design implications
Årsand, E., Frøisland, D. H., Skrøvseth, S. O., Chomutare, T., Tatara, N., Hartvigsen, G., & Tufano, J. T. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600525 · Cited by 214 · cited 2×
“Many app features were poorly utilized, including diet and exercise tracking, which have previously shown to play an important role in T2DM self-management [10].”
Saffari, M., Ghanizadeh, G., & Koenig, H. G. (2014) · Primary Care Diabetes · doi:10.1016/j.pcd.2014.03.004 · Cited by 170
Goyal, S., Nunn, C. A., Rotondi, M., Couperthwaite, A. B., Reiser, S., Simone, A., Katzman, D. K., Cafazzo, J. A., & Palmert, M. R. (2017) · JMIR mHealth and uHealth · doi:10.2196/mhealth.7336 · Cited by 146 · cited 2×
“However, the use of a second phone to deliver eHealth interventions has been a noted barrier to usage in previous studies, and future mobile app evaluations would likely benefit from allowing participants to use their own smartphones when possible [28].”
Pal, K., Dack, C., Ross, J., Michie, S., May, C., Stevenson, F., Farmer, A., Yardley, L., Barnard, M., & Murray, E. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.8439 · Cited by 139
Dropout from an eHealth intervention for adults with type 2 diabetes: a qualitative study
Lie, S. S., Karlsen, B., Oord, E. R., Graue, M., & Oftedal, B. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.7479 · Cited by 136 · cited 1×
“Several recent studies of apps for T2DM have emphasized the importance of an implementation that includes a strong clinical endorsement and ongoing clinical support to increase overall usage [33,34].”
Desveaux, L., Shaw, J., Saragosa, M., Soobiah, C., Marani, H., Hensel, J., Agarwal, P., Onabajo, N., Bhatia, R. S., & Jeffs, L. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.8712 · Cited by 133
Self-citationWorswick, J., Wayne, S. C., Bennett, R., Fiander, M., Mayhew, A., Weir, M. C., Sullivan, K. J., & Grimshaw, J. M. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-26 · Cited by 130 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
Alvarado, M. M., Kum, H.-C., Gonzalez Coronado, K., Foster, M. J., Ortega, P., & Lawley, M. A. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6382 · Cited by 95 · cited 2×
“Therefore, a successful implementation and evaluation of these apps require careful consideration of factors that impact patient app utilization [30].”
Siminerio, L. M., Ruppert, K. M., & Gabbay, R. A. (2013) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721713492570 · Cited by 91 · cited 1×
“In addition, OHIP covers services provided by DEPs, which are multidisciplinary, nonphysician -led programs designed to deliver self-management education of diabetes and self-management support [16].”
Morrison, L. G., Hargood, C., Lin, S. X., Dennison, L., Joseph, J., Hughes, S., Michaelides, D. T., Johnston, D., Johnston, M., Michie, S., et al. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3579 · Cited by 79 · cited 1×
“In addition, it is increasingly evident that digital health apps designed to improve chronic disease self-management require ongoing patient engagement as a key determinant of clinical impact [26-30].”
Katz, R., Mesfin, T., & Barr, K. (2012) · Journal of Health Communication · doi:10.1080/10810730.2012.650613 · Cited by 74
Mixed-methods analysis of factors impacting use of a postoperative mHealth app
Scott, A. R., Alore, E. A., Naik, A. D., Berger, D. H., & Suliburk, J. W. (2017) · JMIR mhealth and uhealth · doi:10.2196/mhealth.6728 · Cited by 67 · cited 1×
“Previous studies have shown patient factors including age, internal motivation, and personal values impact utilization of mobile health technologies [31].”
Hartin, P. J., Nugent, C. D., McClean, S. I., Cleland, I., Tschanz, J. T., Clark, C. J., & Norton, M. C. (2016) · JMIR mHealth and uHealth · doi:10.2196/mhealth.4878 · Cited by 64 · cited 1×
“In addition, it is increasingly evident that digital health apps designed to improve chronic disease self-management require ongoing patient engagement as a key determinant of clinical impact [26-30].”
Bardus, M., Blake, H., Lloyd, S., & Suzanne Suggs, L. (2014) · International Journal of Workplace Health Management · doi:10.1108/ijwhm-11-2013-0040 · Cited by 54
McMillan, K. A., Kirk, A. F., Hewitt, A., & MacRury, S. M. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816656018 · Cited by 51 · cited 1×
“These studies of mobile apps for T2DM largely consist of small single-site studies with a homogeneous population [8,25].”
Desveaux, L., Agarwal, P., Shaw, J., Hensel, J. M., Mukerji, G., Onabajo, N., Marani, H., Jamieson, T., Bhattacharyya, O. K., Martin, D., et al. (2016) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-016-0381-5 · Cited by 51 · cited 2×
“A full description of the protocol has been previously published [17].”
Self-citationTelehealth—An Effective Delivery Method for Diabetes Self-Management Education?
Fitzner, K., & Moss, G. (2013) · Population Health Management · doi:10.1089/pop.2012.0054 · Cited by 45
Reasons for non-participation in a primary care-based physical activity trial: a qualitative study
Attwood, S., Morton, K., Mitchell, J., Emmenis, M. V., & Sutton, S. R. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011577 · Cited by 44 · cited 1×
“Future implementations of digital health apps would benefit from a clear effort to include factors that improve engagement, including a strong clinical endorsement, ongoing physician involvement, and patient reminders [35].”
Andrews, S. M., Sperber, N. R., Gierisch, J. M., Danus, S. M., Macy, S., Bosworth, H. B., Edelman, D. E., & Crowley, M. J. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s125673 · Cited by 22 · cited 1×
“In addition, it is increasingly evident that digital health apps designed to improve chronic disease self-management require ongoing patient engagement as a key determinant of clinical impact [26-30].”
Gude, W. T., van der Veer, S. N., de Keizer, N. F., Coiera, E. W., & Peek, N. B. (2016) · Studies in health technology and informatics · doi:10.3233/978-1-61499-678-1-594 · Cited by 14 · cited 1×
“…the importance of contextual and implementation factors, including clinician training, integration into existing workflows, and ongoing clinician engagement with the patient as important influencers of clinical outcomes [15], yet previous studies were not designed to assess these factors.”
BackgroundBovbjerg, M. L., Lee, J., Wolff, R., Bangs, B., & May, M. A. (2017) · Clinical Diabetes · doi:10.2337/cd17-0006 · Cited by 7 · cited 1×
“There are a growing number of mobile apps designed to improve the self-management of T2DM patients [10-12], although few have been rigorously evaluated.”
Research works printed but not linked: 1
- Gude, W, 2016, Stud Health Technol Inform, 228, 594
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Deniz-Garcia, A., Fabelo, H., Rodriguez-Almeida, A. J., Zamora-Zamorano, G., Castro-Fernandez, M., Alberiche Ruano, M. D. P., Solvoll, T., Granja, C., Schopf, T. R., Callico, G. M., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/44030 · Cited by 268
Smartphone-Based Technology in Diabetes Management
Doupis, J., Festas, G., Tsilivigos, C., Efthymiou, V., & Kokkinos, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00768-3 · Cited by 133
Lee, Y., Kim, G., Jun, J. E., Park, H., Lee, W. J., Hwang, Y., & Kim, J. H. (2023) · Diabetes Care · doi:10.2337/dc22-1929 · Cited by 132
Artificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00154-2 · Cited by 106
Self-citation
Metadata
- Authors
- Agarwal, P., Mukerji, G., Desveaux, L., Ivers, N. M., Bhattacharyya, O., Hensel, J. M., Shaw, J., Bouck, Z., Jamieson, T., Onabajo, N., Cooper, M., Marani, H., Jeffs, L., & Bhatia, R. S.
- Affiliations
- University of Toronto (CA)
- Women's College Hospital (CA)
- St. Michael's Hospital (CA)
- Corresponding author
- Agarwal, Payal
- ORCID
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2019-01-10
- Volume
- 7
- Issue
- 1
- Pages
- e10321
- ISSN
- 2291-5222 (ISSN-L)
- PMC
- PMC6329896
- OpenAlex
- W2891497594
- Cited by
- 208
- References
- 41
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 39 · 2023: 32 · 2022: 32 · 2021: 35 · 2020: 18 · 2019: 5
- FWCI
- 22.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR mhealth and uhealth (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, mobile health apps, diabetes self-management, glycemic control, HbA1c, app usage, diabetes self-efficacy, quality of life, health care utilization, real-world evidence, patient experience, Problem Areas in Diabetes, Summary of Diabetes Self-Care Activities, EuroQol
- MeSH terms
- Self-Management, Adult, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Ontario, Surveys and Questionnaires, Blood Glucose Self-Monitoring, Mobile Applications, Pragmatic Clinical Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.